INTECH Investment Management’s Xeris Biopharma Holdings XERS Stock Holding History

INTECH Investment Management’s Portfolio XERS Stock Details XERS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$278K	Sell	35,108 -1,133	-3%	-$7.24K	﹤0.01%	1619
2026 Q1	$210K	Sell	36,241 -28,849	-44%	-$191K	﹤0.01%	1732
2025 Q4	$511K	Buy	65,090 +9,754	+18%	+$76.8K	﹤0.01%	1507
2025 Q3	$450K	Sell	55,336 -39,101	-41%	-$260K	﹤0.01%	1635
2025 Q2	$441K	Buy	94,437 +44,330	+88%	+$203K	﹤0.01%	1677
2025 Q1	$275K	Sell	50,107 -8,841	-15%	-$35.7K	﹤0.01%	1938
2024 Q4	$200K	Buy	58,948 +13,340	+29%	+$42.9K	﹤0.01%	2034
2024 Q3	$130K	Buy	+45,608	New	+$117K	﹤0.01%	1837

Other funds holding XERS

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return

Rosalind Advisors Toronto, Ontario, Canada $269M AUM 103.38% 1-Year Est. Return

Qube Research & Technologies (QRT) London, United Kingdom $108B AUM 37.29% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

INTECH Investment Management's XERS Position: Q2 2026 in Review

INTECH Investment Management reduced its Xeris Biopharma Holdings (XERS) stake by 3.1% in Q2 2026, selling an estimated $7.24K and leaving 35,108 shares worth $278K. The position accounts for ﹤0.01% of the portfolio, ranked #1619.

INTECH Investment Management first reported a position in XERS in Q3 2024 and has held it in 8 quarters since. The position peaked at $511K in Q4 2025. 240 funds tracked by Wall St. Rank hold XERS as of Q2 2026.

INTECH Investment Management held 35,108 shares of Xeris Biopharma Holdings worth $278K as of Q2 2026.
INTECH Investment Management sold 1,133 Xeris Biopharma Holdings shares in Q2 2026, an estimated $7.24K.
Xeris Biopharma Holdings made up ﹤0.01% of INTECH Investment Management's portfolio in Q2 2026, its #1619 holding.
INTECH Investment Management first reported a position in Xeris Biopharma Holdings in Q3 2024 and has held it in 8 quarters since.
INTECH Investment Management's Xeris Biopharma Holdings position peaked at $511K in Q4 2025.
240 funds tracked by Wall St. Rank held Xeris Biopharma Holdings as of Q2 2026.

Based on INTECH Investment Management's 13F filing for Q2 2026, filed 10 Aug 2026.